CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.

Autor: Reusing SB; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology and Clinical Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany., Vallera DA; Department of Therapeutic Radiology-Radiation Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Vatrin T; Department of Pediatric Oncology, Hematology and Clinical Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany., Bhatia S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany., Felices M; Department of Medicine, Division of Hematology, Oncology and Transplantation, Minneapolis, MN, USA., Miller JS; Department of Medicine, Division of Hematology, Oncology and Transplantation, Minneapolis, MN, USA., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Babor F; Department of Pediatric Oncology, Hematology and Clinical Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany. Florian.Babor@med.uni-duesseldorf.de.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Dec; Vol. 70 (12), pp. 3701-3708. Date of Electronic Publication: 2021 Aug 16.

Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells.

Autor: Bennstein SB; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Scherenschlich N; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Weinhold S; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Noll A; Primate Genetics Laboratory, German Primate Center, Leibnitz-Institute for Primate Research, Göttingen, Germany., Raba K; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Kögler G; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Walter L; Primate Genetics Laboratory, German Primate Center, Leibnitz-Institute for Primate Research, Göttingen, Germany., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Publikováno v: Stem cells translational medicine [Stem Cells Transl Med] 2021 Jun; Vol. 10 (6), pp. 867-882. Date of Electronic Publication: 2021 Jan 21.

Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.

Autor: Babor F; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. florian.babor@med.uni-duesseldorf.de., Peters C; Department of Paediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Glogova E; Department of Paediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Sauer M; Department of Pediatric Hematology/Oncology and Blood Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Pötschger U; Department of Paediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Ahlmann M; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Cario G; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany., Feuchtinger T; Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner'sches Kinderspital, Ludwig-Maximilians-University München, Munich, Germany., Gruhn B; Department of Pediatrics, Jena University Hospital, Jena, Germany., Güngör T; Division of Stem Cell Transplantation, Department of Pediatrics, University Children's Hospital, Zürich, Switzerland., Horn PA; Institute for Transfusion Medicine, University Hospital, Essen, Germany., Kremens B; Department of Paediatrics III, University Hospital, Essen, Germany., Lang P; Children's Hospital, University of Tuebingen, Tübingen, Germany., Mezger M; Children's Hospital, University of Tuebingen, Tübingen, Germany., Müller I; Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mytilineos J; Institute for Clinical Transfusion Medicine & Immunogenetics Ulm, Ulm, Germany., Oevermann L; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Pichler H; Department of Paediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Scherenschlich N; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Schuster FR; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Siepermann M; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Stachel D; Department of Pediatric Hematology and Oncology, Children's Hospital, University of Erlangen, Erlangen, Germany., Strahm B; Division of Pediatric Hematology and Oncology, University Children's Hospital Freiburg, Freiburg, Germany., Wössmann W; Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany., Escherich G; Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zimmermann M; Department of Pediatric Hematology/Oncology and Blood Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Schrappe M; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany., Borkhardt A; Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Eckert C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bader P; Department of Pediatric Stem Cell Transplantation and Immunology, Children's Hospital, Johann Wolfgang Goethe-University, Frankfurt, Germany., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany. markus.uhrberg@med.uni-duesseldorf.de., Meisel R; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. meisel@med.uni-duesseldorf.de.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2019 Nov; Vol. 54 (11), pp. 1847-1858. Date of Electronic Publication: 2019 May 14.

HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.

Autor: Thöns C; Institute for Virology, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany., Senff T; Institute for Virology, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany., Hydes TJ; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK., Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany., Heinemann FM; Institute for Transfusion Medicine, University of Duisburg-Essen, University Hospital, Essen, Germany., Heinold A; Institute for Transfusion Medicine, University of Duisburg-Essen, University Hospital, Essen, Germany., Heilmann M; Department for Addiction Medicine and Addictive Behavior, LVR-Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany., Kim AY; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany., Scherbaum N; Department for Addiction Medicine and Addictive Behavior, LVR-Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany., Lauer GM; Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Khakoo SI; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK., Timm J; Institute for Virology, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany. Electronic address: joerg.timm@med.uni-duesseldorf.de.

Publikováno v: Journal of hepatology [J Hepatol] 2017 Sep; Vol. 67 (3), pp. 462-470. Date of Electronic Publication: 2017 Apr 13.

Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance.

Autor: Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. Markus.Uhrberg@med.uni-duesseldorf.de.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2016 Apr; Vol. 65 (4), pp. 417-26. Date of Electronic Publication: 2015 Aug 19.